logo
episode-header-image
Jul 2023
40m 47s

AI and Ozempic: The two great disruptive...

Fast Company
About this episode

AI is poised to upend the music industry, and Fast Company Associate Editor David Salazar joins us to discuss what AI generative music is and how the music industry is combating it.

Antidiabetic medication Ozempic is all over the news these days, but it's not as new as it seems. Beyond the TikTok trends and celebrity shout-outs, it's been used to treat diabetes for years. But now talk of this medication has reached a fever pitch.

Found CEO Sarah Jones Simmer talks about how her company prioritizes comprehensive weight care management, the ongoing discussion about Ozempic, and the very complicated history of weight in this country. Basically, how do we thread the needle between self-acceptance and positive body image and the existing health challenges, like the skyrocketing rates of diabetes?

Then we discuss Barbenheimer because, well, we have to.

Up next
Jan 2025
Teflon Son? How Softbank CEO Masayoshi Son’s legend keeps growing
On today’s episode, host Josh Christensen is joined by ‘Fast Company’ associate editor David Salazar to help break down the latest news in the world of business and innovation, including the fallout from DeepSeek’s LLM launch, the backtracked federal funding freeze, and the risin ... Show More
1h 3m
Jan 2025
Police departments are embracing AI-enhanced surveillance technology to stop crime
Police departments across the country are embracing AI-enhanced surveillance technology in the name of stopping crime. One prominent security firm called Flock Safety is leading the effort and profiting off our fears. Fast Company Senior Writer Ainsley Harris joined Yaz and Josh ... Show More
56m 34s
Dec 2024
Why the NFL, Universal Pictures, and erotic audio company Quinn made our Brands That Matter list
On today’s episode, Yaz and Josh are joined by ‘Fast Company’ senior staff editor Jeff Beer and ‘Fast Company’ associate editor David Salazar to discuss the annual Brands That Matter list. This year, the list includes not just such companies as Athletic Brewing, Quinn Erotic Audi ... Show More
1h 11m
Recommended Episodes
Jul 2023
Big Food, Big Tech and Big AI with Michael Moss
In the next two episodes of Your Undivided Attention, we take a close look at two respective industries: big food and social media, which represent dangerous “races to the bottom” and have big parallels with AI. And we are asking: what can our past mistakes and missed opportuniti ... Show More
34m 43s
Nov 2023
2023 Ask Us Anything
You asked, we answered. This has been a big year in the world of tech, with the rapid proliferation of artificial intelligence, acceleration of neurotechnology, and continued ethical missteps of social media. Looking back on 2023, there are still so many questions on our minds, a ... Show More
35m 7s
Jun 2018
540: How WeGo Health Are Uniting Patient Leaders and Experts
WEGO Health is on a mission-driven company connecting healthcare with the experience, skills, and insights of Patient Leaders. They are the world’s largest network of Patient Leaders, working across virtually all health conditions and topics. The WeGo Health network collaborates ... Show More
25m 23s
Jan 2024
Novo Nordisk (Ozempic)
Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about ... Show More
3h 42m
Jul 2023
How Drugs Like Ozempic Are Changing What We Think About Weight Loss
You may have heard about Ozempic, Wegovy and Mounjaro. It’s tough to miss the online chatter, the ads on TV and all the news coverage. They are part of a class of drugs originally designed to treat diabetes, and all three have been shown to help people lose significant amounts of ... Show More
30m 50s
Oct 2023
Semaglutide: Decoding the hype around the weight loss wonder drug
From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becoming a ... Show More
32m 7s
Jul 2024
What really went down at OpenAI and the future of regulation w/ Helen Toner (from The TED AI Show)
Here on Fixable, we've addressed countless tough problems people face at work. One of the toughest problems companies deal with is when leaders don't see eye to eye. We know you enjoyed our previous episode about OpenAI, so we thought we'd share more insight into how the company ... Show More
40m 56s
Jun 2024
The music industry’s AI fight
The Verge's Nilay Patel and David Pierce chat with Switched on Pop's Charlie Harding about the RIAA lawsuit against AI music startups Udio and Suno. Later, Nilay and David discuss the rest of this week's tech and gadget news. Further reading: What the RIAA lawsuits against Udio a ... Show More
1h 28m
Jan 2022
The race to build AI that benefits humanity | Sam Altman
Will innovation in artificial intelligence drastically improve our lives, or destroy humanity as we know it? From the unintended consequences we've suffered from platforms like Facebook and YouTube to the danger of creating technology we can't control, it's easy to see why people ... Show More
1h 8m
Sep 2023
How ChatGPT is launching tech’s next big wave
OpenAI is reportedly nearing $1 billion in annual sales. There’s an AI arms race among big tech companies. AI is everywhere and on everyone’s mind, so we’re breaking it all down. Fast Company senior writer Mark Sullivan explains who the major players are—from Nvidia to Anthropic— ... Show More
40m 16s